Kristine Hoffman, DPM
Foot & Ankle Surgery · Boulder, CONPI 1336396308
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $6,000 of the $8,995 with a category attached, or 66.7%. Arthrex accounts for 88.2% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2022 at $8,019 and has fallen 96.0% since, to $324 in 2025.
Across 55 payments — averaging $163.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$8K
- Stryker$287
- Johnson & Johnson$191
- Aroa Biosurgery Incorporated$111
- Paragon 28, Inc.$95
- Smith+Nephew$63
- plus $315 from 10 others
What the payments were for
- Speaking & faculty fees$6,00067%
- Travel & lodging$1,57117%
- Food & beverage$1,42416%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 22 | $7,933 |
| Stryker | 7 | $287 |
| Johnson & Johnson | 5 | $191 |
| Aroa Biosurgery Incorporated | 4 | $111 |
| Paragon 28, Inc. | 1 | $95 |
| Smith+Nephew | 2 | $63 |
| Gemini Mountain Medical, LLC | 2 | $60 |
| Bioventus LLC | 2 | $57 |
| Bone Support Inc. | 2 | $36 |
| Kerecis Limited | 1 | $34 |
| Zimmer Biomet | 2 | $29 |
| Acell, Inc. | 1 | $23 |
| Organogenesis Inc. | 1 | $22 |
| Biocomposites Inc | 1 | $20 |
| Integra Lifesciences Corporation | 1 | $19 |
| Solventum Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- N/A$143
How this compares
$8,995 in reported general payments places this provider in the 75th percentile of 181 foot & ankle surgery providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 11 | $205 |
| Oxycodone Hcl | 11 | $50 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Boulder
- Aditya YerrapragadaBoulder$8K
- Michael HoughtonFort Collins$2M
- Joshua MetzlEnglewood$1.8M
- Brad DresherColorado Springs$1.3M
- Thomas ClantonVail$1.1M
- Brett SachsWheat Ridge$806K
- Jeffrey LehrmanFort Collins$628K
- Kevin NagamaniDenver$288K
- Keith JacobsonDenver$241K
- William MontrossColorado Springs$238K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.